One of those things is the CureDuchenne clinic in Denton. It provides care to underserved and uninsured people with Duchenne. "I think it's good that we're trying to find the cure," Shep said.

MISSISSAUGA, ON, Oct. 2, 2025 /CNW/ - Kye Pharmaceuticals ("Kye") announced today that Health Canada has approved AGAMREE® (vamorolone) for the treatment of Duchenne Muscular Dystrophy (DMD) in boys a ...

Approximately 16 boys with Duchenne Muscular Dystrophy (DMD), including several teenagers, are set to benefit from the drug, ...

Capricor Therapeutics is advancing deramiocel (CAP-1002) for DMD cardiomyopathy. Click here to find out why CAPR stock is a ...

Data from ongoing DELIVER trial demonstrated sustained functional improvement through 18 months; results from Registrational Expansion Cohort ...

– Late-breaking presentation at ESC Congress 2025 confirms that early, persistent lowering of LDL-C and blood pressure leads to improved cardiovascular health outcomes – – Raised over $50 million to ...

After three patients died, the maker of an investigational gene therapy stopped shipments of the drug after it refused to ...

For Beau and JeanAnn Bryan, the fight to save their sons has become a race against time — and they’re calling on their ...

FDA and Capricor aligned on endpoints for HOPE-3 pivotal trialHOPE-3 pivotal trial completed; topline data expected mid-Q4 2025 to support BLA ...

Duchenne therapy may be evolving from slowing disease to reversing it—with RNA approaches offering the prospect of restoring ...